Observational analysis revealed significant reductions in depression and anxiety symptoms, indicating potential for AI support in mental health care.
Heinz et al. reported that a 4-week generative AI (GenAI) treatment, Therabot, produced clinically significant reductions in depression, anxiety, and eating disorder symptoms after 4 and 8 weeks. The Therabot group was compared with a wait-list control group, a likely nocebo. Comparing Therabot with an attention-equivalent control group — such as participants using message boards, online support groups, or chat rooms — would have increased the study's credibility. Comparing Therabot with 4 weeks of treatment provided by human therapists would have been ideal.
No takes yet. Share an insight, caveat, or question.
Heckman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: